(Total Views: 843)
Posted On: 11/10/2020 3:50:01 PM
Post# of 153903
Don't you get it yet? The FDA is not going to give Leronlimab EUA because it is in two trials and the S/C trial is more important.
Approval is not just about p values and safety. The FDA also considers supply and other logistical considerations. Also price. Watch the video interview I posted a link to with Dr. Janet Woodcock.
https://www.cnbc.com/video/2020/10/15/healthy...dcock.html
It is apparent now that the FDA sees the whole situation as a very big pie to be sliced up according to who they believe can address their slice most adequately. Our slice so far, the S/C population, is small but, boy, is it spicy! Only we can address it so it is ours.
I am so sick and tired of the peanut gallery impuning bad motives to the FDA and others which, to us, are black boxes and we don't see all the factors for their decisions involved. Nor do many in the peanut gallery really care about the factors involved - they just want to speak from their motive, greed! Well too bad your stock isn't going up today! Waaaaaaa!
The rest of us are doing as Nader suggests and focusing on the fundamentals and giving things time to work out.
Today is a terrific opportunity to average down or buy more if you are up. I liked this stock at much higher prices, so why wouldn't I like it now? Nothing has fundamentally changed for the fortunes of Cytodyn and Leronlimab, except our looming expansion into treating Longhaulers! Do we have any competitors there?
Who wants an Immunity System tune-up? I do!
Approval is not just about p values and safety. The FDA also considers supply and other logistical considerations. Also price. Watch the video interview I posted a link to with Dr. Janet Woodcock.
https://www.cnbc.com/video/2020/10/15/healthy...dcock.html
It is apparent now that the FDA sees the whole situation as a very big pie to be sliced up according to who they believe can address their slice most adequately. Our slice so far, the S/C population, is small but, boy, is it spicy! Only we can address it so it is ours.
I am so sick and tired of the peanut gallery impuning bad motives to the FDA and others which, to us, are black boxes and we don't see all the factors for their decisions involved. Nor do many in the peanut gallery really care about the factors involved - they just want to speak from their motive, greed! Well too bad your stock isn't going up today! Waaaaaaa!
The rest of us are doing as Nader suggests and focusing on the fundamentals and giving things time to work out.
Today is a terrific opportunity to average down or buy more if you are up. I liked this stock at much higher prices, so why wouldn't I like it now? Nothing has fundamentally changed for the fortunes of Cytodyn and Leronlimab, except our looming expansion into treating Longhaulers! Do we have any competitors there?
Who wants an Immunity System tune-up? I do!
(13)
(1)
